September Is Ovarian Cancer Awareness Month
Many women dismiss the seemingly benign symptoms of ovarian cancer.
Read more on Local 10 Miami
Celgene Officially Notified of ANDA Filing for REVLIMID®
SUMMIT, N.J.–(BUSINESS WIRE)–Celgene Corporation (NASDAQ: CELG) today announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA). The application requests authorization to manufacture and market generic versions of REVLIMID® …
Read more on Business Wire
Celgene Officially Notified of ANDA Filing for REVLIMID®
SUMMIT, N.J.—-Celgene Corporation today announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application to the U.S.
Read more on Business Wire via Yahoo! Finance
Related posts:
You must be logged in to post a comment.